Overview

We would like to invite GPs to this webinar on supporting patients with concerns about PFAS exposure. Community concern around PFAS exposure and health effects can lead to anxiety and challenging consultations for general practitioners. GPs are a trusted health provider and can be the first point of contact for patients concerned about PFAS-related health effects. 

The webinar will draw on public health and toxicology expertise, and risk communication principles to support GPs to manage and navigate PFAS-related health consultations effectively. 

The event will include presentations on current situation in the Blue Mountains, overview of PFAS epidemiology, current evidence on health effects, and resources available to support patient consultations related to PFAS. 

Prior to the webinar, GPs can send through any case studies or specific questions by 11 July 2025. Alternatively, there will be an opportunity to pose questions in the Q&A component.

Learning outcomes:

By the end of the activity participants should be able to: 

• Understand the current situation with PFAS in the Blue Mountains 
• Understand the range of exposure to PFAS in the Australian population
• Know more about the evidence for the potential adverse health effects of PFAS exposure
• Be able to counsel patients on their risk, the utility of blood tests, and the role of further investigations and management

Audience

GPs, local health district staff

Presenter Details

Ms Stephanie Gonzales, Manager Environmental Health, NBMPHN

Dr Debra King, General Practitioner

Professor Nick Buckley, Professor of Clinical Pharmacology, University of Sydney

Professor Tim Driscoll, School of Public Health, University of Sydney

Dr Claire Hooker, Associate Professor in Health and Medical Humanities, Sydney Heath Ethics, University of Sydney

Professor Alison Jones, Executive Director, Sunshine Coast Health Institute